Interestingly, it manifested that the expression of SNHG22 had no significant differentials between MCF-10A cells and hormone dependent breast cancer cell lines (MCF7 and T47D) or HER2-positive breast cancer cell lines (MDA-MB-453 and SKBR3) (Fig. 6b). The gene discussed is SNHG22; the disease is breast cancer.